Tag: arv766

Non-invasive prenatal testing linked to decreased diagnostic testing

Novartis: ARV-766 is an androgen receptor degrader efficacious in treating metastatic prostate cancer

byYidi Wangand1 others

May 19, 2024

In patients with metastatic prostate cancer, ARV-766 treatment led to a greater than 50% reduction in Prostate-Specific antigen (PSA) in ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial
Natural language processing (NLP) model sped up patient message management in the electronic health record (EHR)
Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

No Result

View All Result